Amézaga, J., Alfaro, B., Ríos, Y., Larraioz, A., Ugartemendia, G., Urruticoechea, A., & Tueros, I. (2018). Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment. Supportive Care in Cancer, 26(12), 4077-4086
Bernhardson, B.-M., Tishelman, C., & Rutqvist, L. E. (2007). Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. Journal of Pain and Symptom Management, 34(4), 403-412.
Belqaid, K., Tishelman, C., Orrevall, Y., Månsson-Brahme, E., &Bernhardson, B.-M. (2018). Dealing with taste and smell alterations—A qualitative interview study of people treated for lung cancer. PloS one, 13(1), e0191117
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative research in psychology, 3(2), 77-101.
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68(6), 394-424. doi:10.3322/caac.21492.
Brisbois, T. D., de Kock, I. H., Watanabe, S. M., Baracos, V. E., &Wismer, W. V. (2011). Characterization of chemosensory alterations in advanced cancer reveals specific chemosensory phenotypes impacting dietary intake and quality of life. Journal of Pain and Symptom Management, 41(4), 673-683.
Bozzetti, F., Mariani, L., Lo Vullo, S., Amerio, M. L., Biffi, R., Caccialanza, G., .Vigevani, E. (2012). Thenutritional risk in oncology: a study of 1,453 cancer outpatients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 20(8), 1919-1928. doi:10.1007/s00520-012-1387-x
De Vries, Y. C., Winkels, R. M., van den Berg, M. M. G. A., de Graaf, C., Kelfkens, C. S., de Kruif, J. T. C. M., . . . Boesveldt, S. (2018). Altered food preferences and chemosensory perception during chemotherapy in breast cancer patients: A longitudinal comparison with healthy controls.
Food Quality and Preference, 63, 135-143. doi:
https://doi.org/10.1016/j.foodqual.2017.09.003
Drareni, K., Dougkas, A., Giboreau, A., Laville, M., Souquet, P.-J., &Bensafi, M. (2019). Relationship between food behavior and taste and smell alterations in cancer patients undergoing chemotherapy: A structured review. Paper presented at the Seminars in oncology.
Espy, D. D., Yang, F., Bhatt, T., & Pai, Y.-C. (2010). Independent influence of gait speed and step length on stability and fall risk. Gait & posture, 32(3), 378-382.
Halyard, M. Y. (2009). Taste and smell alterations in cancer patients--real problems with few solutions. J Support Oncol, 7(2), 68-69.
Harman, L. E. (2016). Ophthalmic complications related to chemotherapy in medically complex patients. Cancer Control, 23(2), 150-156.
Haugnes, H. S., Stenklev, N. C., Brydøy, M., Dahl, O., Wilsgaard, T., Laukli, E., &Fosså, S. D. (2018). Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study. Acta Oncologica, 57(8), 1075-1083. doi:10.1080/0284186X.2018.1433323
Marnitz, S., Schermeyer, L., Dommerich, S., Köhler, C., Olze, H., Budach, V., &Martus, P. (2018). Age-corrected hearing loss after chemoradiation in cervical cancer patients. Strahlentherapie und Onkologie, 194(11), 1039-1048. doi:10.1007/s00066-018-1347-6
Monfort, S. M., Pan, X., Patrick, R., Ramaswamy, B., Wesolowski, R., Naughton, M. J., . . . Lustberg, M. B. (2017). Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients. Breast cancer research and treatment, 164(1), 69-77.
Moll, A. C., de Boer, M. R., Bouter, L. M., & Singh, N. (2019). Principles of Cancer Epidemiology. In A. D. Singh & B. E. Damato (Eds.), Clinical Ophthalmic Oncology: Basic Principles (pp. 1-10). Cham: Springer International Publishing.
Noszek, L., Budai, B., Prekopp, P., Széchenyi, R., Szőnyi, M., Talpai, S., . . . Geczi, L. (2017). Early ototoxic changes in patients withgerm cell tumor after first cycle of cisplatin‐based therapy. The Laryngoscope, 127(8), E277-E282.
Omoti, A., &Omoti, C. (2006). Ocular toxicity of sys(Miller et al., 2016)temic anticancer chemotherapy. Pharmacy practice, 4, 55-59.
Rhodes, V. A., McDaniel, R. W., Hanson, B., Markway, E., & Johnson, M. (1994). Sensory perception of patients on selected antineoplastic chemotherapy protocols. Cancer Nursing, 17(1), 45-51.
Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., . . . Fallon, M. (2014). Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain, 155(12), 2461-2470. doi:10.1016/j.pain.2014.09.020
Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69(1), 7-34.
Stout, N. L., & Sabo Wagner, S. (2019). Antineoplastic Therapy Side Effects and Polypharmacy in Older Adults With Cancer. Topics in Geriatric Rehabilitation, 35(1), 15-30. doi:10.1097/tgr.
Thiermann, F., & Buchbauer, G. (2017). Influence of drugs on smelling capacity. A review. Flavour and Fragrance Journal, 32(3), 147-158.
van Oort, S., Kramer, E., de Groot, J.-W., & Visser, O. (2018). Taste alterations and cancer treatment. Current opinion in supportive and palliative care, 12(2), 162-167.
Zabernigg, A., Gamper, E. M., Giesinger, J. M., Rumpold, G., Kemmler, G., Gattringer, K., ... & Holzner, B. (2010). Taste alterations in cancer patients receiving chemotherapy: a neglected side effect?. The oncologist, 15(8), 913.